NEOCongressional Stock Trades
NeoGenomics, Inc.
Services-Testing Laboratories
Congressional stock trades in NeoGenomics, Inc. (NEO) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
2
Politicians Trading
1
Last Traded
Aug 7, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr.D | Sep 10, 2026 | Aug 7, 2026 | Buy | $1,001 - $15,000 | -0.48% |
| Gilbert Ray Cisneros, Jr.D | Jun 6, 2025 | May 7, 2025 | Buy | $1,001 - $15,000 | +106.12% |
Price History
About NeoGenomics, Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
1 members of Congress have disclosed 2 trades in NeoGenomics, Inc. (NEO). Most active: Gilbert Ray Cisneros, Jr. (2).
Across all disclosures, members of Congress reported 2 purchases and 0 sales of NeoGenomics, Inc. (NEO). The most recent trade was on Aug 7, 2026.
Gilbert Ray Cisneros, Jr. disclosed buying NeoGenomics, Inc. (NEO) on Aug 7, 2026, valued at $1,001 - $15,000.
From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.